1.The antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention
Linlin MAI ; Yunzhao HU ; Yanxian WU ; Haichun OUYANG ; Yingwen CHEN ; Hangying WANG
The Journal of Practical Medicine 2015;31(16):2637-2640
Objective To compare the efficacy and safety of singular double antithrombotie therapy (DT) using warfarin plus clopidogrel and the combined antithrombotie therapy of 3-month triple antithrombotie therapy (TT) using warfarin, aspirinand clopidogrel and 9-month double antithrombotie therapy (DT) for the patients with atrial fibrillation undergoing PCI. Methods Ninety patients with atrial fibrillation undergoing PCI were randomly divided into two groups evenly: one group was treated with dual antithrombotic therapy group (DT) and the other group with the combined therapy, e. g. 3-month triple antithrombotie therapy (TT) and 9-month double antithrombotie therapy (DT + TT for short). All patients were followed-up by 12 months. The two groups were compared in terms of incidences of death , myocardial infarction , stroke , target-vessel revascularisation , stent thrombosis and bleeding adverse events. Results The incidences of myocardial infarction, stroke, target-vessel revascularisation , stent thrombosis and bleeding adverse events in the TT + DT group were all significantly lower than the DT group (P < 0.05). The follow-up on the safety indicated that the rate of bleeding in the TT +DT group was insignificantly higher than the DT group (P > 0.05). Conclusion There is no significant difference in safety between the two groups. However, the therapy of TT + DT is more effective.
2.Analysis of Hospitalization Expenses about 7 Cancers in a West Northern County in 2014
Qiang WANG ; Xiaoyang LIU ; Jianbiao HUA ; Hangying QU ; Yun MEN ; Jiansheng WANG
Modern Hospital 2018;18(5):662-665
Objective To analyze the influencing factors of hospitalization costs for cancer patients in a county in Northwestern China, and to provide a theoretical basis for the health department to optimize the allocation of medical resources and improve the diagnosis and treatment of cancer in primary hospitals. Methods Using the data of the tumor registration report of a county hospital in northwestern China, the data of 7 common cancer patients in a county in northwestern China in2014 were collected. Use the R3. 3. 1 statistical software to perform t-tests and logistic regression analysis on the factors that influence the average hospitalization costs. Results The 7 common cancers in a county in northwestern China in 2014 were gastric cancer, lung cancer, liver cancer, esophageal cancer, cervical cancer, breast cancer, and colorectal cancer. The average hospitalization costs for the 7 cancers were 28 270 yuan, 29 630 yuan, and 28 990 respectively. Yuan, 43 950 yuan, 48 810 yuan, 45 620 yuan, 41 340 yuan; The main influencing factors for the average cost of hospitalization for the 7 types of cancer were: hospitalization day, patient age, and location of the patient for medical treatment. Conclusion Accelerating the improvement of the cancer prevention and control system in primary hospitals so that cancer patients can be effectively treated in primary hospitals to reduce personal and socioeconomic burdens.
3.Andrographolide protects against atrial fibrillation by alleviating oxidative stress injury and promoting impaired mitochondrial bioenergetics.
Pengcheng YU ; Jiaru CAO ; Huaxin SUN ; Yingchao GONG ; Hangying YING ; Xinyu ZHOU ; Yuxing WANG ; Chenyang QI ; Hang YANG ; Qingbo LV ; Ling ZHANG ; Xia SHENG
Journal of Zhejiang University. Science. B 2023;24(7):632-649
Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia seen in clinical settings, which has been associated with substantial rates of mortality and morbidity. However, clinically available drugs have limited efficacy and adverse effects. We aimed to investigate the mechanisms of action of andrographolide (Andr) with respect to AF. We used network pharmacology approaches to investigate the possible therapeutic effect of Andr. To define the role of Andr in AF, HL-1 cells were pro-treated with Andr for 1 h before rapid electronic stimulation (RES) and rabbits were pro-treated for 1 d before rapid atrial pacing (RAP). Apoptosis, myofibril degradation, oxidative stress, and inflammation were determined. RNA sequencing (RNA-seq) was performed to investigate the relevant mechanism. Andr treatment attenuated RAP-induced atrial electrophysiological changes, inflammation, oxidative damage, and apoptosis both in vivo and in vitro. RNA-seq indicated that oxidative phosphorylation played an important role. Transmission electron microscopy and adenosine triphosphate (ATP) content assay respectively validated the morphological and functional changes in mitochondria. The translocation of nuclear factor erythroid 2-related factor 2 (Nrf2) to the nucleus and the molecular docking suggested that Andr might exert a therapeutic effect by influencing the Keap1-Nrf2 complex. In conclusions, this study revealed that Andr is a potential preventive therapeutic drug toward AF via activating the translocation of Nrf2 to the nucleus and the upregulation of heme oxygenase-1 (HO-1) to promote mitochondrial bioenergetics.
Animals
;
Rabbits
;
Atrial Fibrillation/metabolism*
;
Kelch-Like ECH-Associated Protein 1/metabolism*
;
Signal Transduction
;
NF-E2-Related Factor 2/pharmacology*
;
Molecular Docking Simulation
;
Oxidative Stress
;
Energy Metabolism
;
Mitochondria/metabolism*
;
Inflammation/metabolism*
;
Heme Oxygenase-1